Key Points
- Movano CFO Jeremy Cogan sold 8,218 shares on Jan. 6 at an average $7.79 (≈$64,018) and had sold 1,879 shares on Jan. 5 at $8.35, trimming his holdings by 35.23% to 15,107 shares — the sales were disclosed in an SEC filing.
- Other insiders, including CTO Michael Aaron Leabman, also sold several thousand shares across Jan. 7–9 at roughly $7.26–$7.34, adding to insider selling pressure on the thinly traded stock.
- Movano shares traded down ~6.9%; the company has a market cap of $5.79M and reported a large EPS loss despite beating estimates, with virtually no revenue ($0.08M vs. ~$3.9M expected) and deeply negative margins and ROE.
Movano Inc. (NASDAQ:MOVE - Get Free Report) CFO Jeremy Cogan sold 1,879 shares of the business's stock in a transaction on Monday, January 5th. The shares were sold at an average price of $8.35, for a total transaction of $15,689.65. Following the sale, the chief financial officer directly owned 23,325 shares in the company, valued at $194,763.75. This trade represents a 7.46% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Jeremy Cogan also recently made the following trade(s):
- On Tuesday, January 6th, Jeremy Cogan sold 8,218 shares of Movano stock. The stock was sold at an average price of $7.79, for a total value of $64,018.22.
Movano Stock Performance
Movano stock opened at $6.97 on Tuesday. The business's 50-day simple moving average is $8.82 and its two-hundred day simple moving average is $7.57. The company has a market cap of $5.79 million, a PE ratio of -0.64 and a beta of 0.79. Movano Inc. has a fifty-two week low of $4.67 and a fifty-two week high of $58.76.
Movano (NASDAQ:MOVE - Get Free Report) last announced its quarterly earnings data on Friday, November 14th. The technology company reported ($4.73) earnings per share (EPS) for the quarter, topping the consensus estimate of ($7.00) by $2.27. The firm had revenue of $0.08 million during the quarter, compared to analysts' expectations of $3.88 million. Movano had a negative return on equity of 647.91% and a negative net margin of 3,409.60%.
Institutional Trading of Movano
An institutional investor recently bought a new position in Movano stock. Citadel Advisors LLC purchased a new stake in shares of Movano Inc. (NASDAQ:MOVE - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 49,262 shares of the technology company's stock, valued at approximately $28,000. Citadel Advisors LLC owned 5.94% of Movano as of its most recent filing with the Securities & Exchange Commission. 16.64% of the stock is owned by institutional investors and hedge funds.
More Movano News
Here are the key news stories impacting Movano this week:
- Positive Sentiment: Short interest fell in late December — as of Dec. 31 there were 43,438 shares short, a 29.1% decline from mid‑December, representing about 5.8% of the float and a low days‑to‑cover (0.5). Lower short interest can reduce downward short‑squeeze pressure.
- Neutral Sentiment: January short‑interest reporting appears inconsistent — an entry shows 0 shares (NaN change) as of Jan. 12, which looks like a data or reporting glitch and should be treated cautiously by traders.
- Negative Sentiment: Insiders selling — Movano’s CFO Jeremy Cogan disclosed two recent sales (1/5 and 1/6), including 8,218 shares on Jan. 6 at an average $7.79 and 1,879 shares on Jan. 5 at $8.35; these reduced his stake materially. See the SEC filing. Read More.
- Negative Sentiment: Additional insider selling — CTO Michael Aaron Leabman sold multiple tranches (Jan. 7–9) totaling several thousand shares at ~ $7.26–$7.34, trimming his holdings by mid‑single digits to low‑double digit percentages. Insider sales at these levels often weigh on small‑cap names with low liquidity. See the SEC filing. Read More.
- Negative Sentiment: Operational/financial context — Movano’s latest reported quarter (Nov. 14) showed a large EPS loss metric but a beat versus consensus; revenue was effectively negligible (~$0.08M vs. est. ~$3.9M) and margins/ROE were deeply negative. For investors, weak top‑line performance and very small revenue at a public company magnify execution and dilution risk.
Analyst Ratings Changes
A number of research firms have recently weighed in on MOVE. Weiss Ratings reiterated a "sell (e+)" rating on shares of Movano in a research note on Wednesday, October 8th. Wall Street Zen raised shares of Movano to a "hold" rating in a report on Saturday, December 20th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has an average rating of "Sell".
Check Out Our Latest Analysis on MOVE
About Movano
(
Get Free Report)
Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company's core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.
Movano's flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
